Lexapro News and Research

RSS
Merck update on the status of telcagepant clinical development programs

Merck update on the status of telcagepant clinical development programs

Biomarkers for rapid identification of treatment effectiveness in major depression

Biomarkers for rapid identification of treatment effectiveness in major depression

New antidepressants might be no more effective than the best existing drugs

New antidepressants might be no more effective than the best existing drugs

United States files complaint against Forest Labs for allegedly violating the false claims act with Celexa and Lexapro

United States files complaint against Forest Labs for allegedly violating the false claims act with Celexa and Lexapro

Anxious seniors may benefit from SSRIs

Anxious seniors may benefit from SSRIs

Antidepressants during pregnancy present remote risk of birth defects

Antidepressants during pregnancy present remote risk of birth defects

FDA - all antidepressants need new warning labels

FDA - all antidepressants need new warning labels

Clinical trial of a medication to treat kleptomania

Clinical trial of a medication to treat kleptomania

FDA warns consumers about buying medications over the Internet

FDA warns consumers about buying medications over the Internet

More physicians now visit web sites to find information on brand-name prescription drugs

More physicians now visit web sites to find information on brand-name prescription drugs

Adverts for SSRI antidepressants misleading

Adverts for SSRI antidepressants misleading

EU calls for tougher warnings on antidepressants for kids

EU calls for tougher warnings on antidepressants for kids

Promising early results in a study of a medication to treat kleptomania

Promising early results in a study of a medication to treat kleptomania

Public Health Advisory for medical professionals with patients on anti-depression medication

Public Health Advisory for medical professionals with patients on anti-depression medication

New and Generic Drug Approvals from FDA

New and Generic Drug Approvals from FDA